LIFR Antikörper (AA 915-1086)
Kurzübersicht für LIFR Antikörper (AA 915-1086) (ABIN7158226)
Target
Alle LIFR Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 915-1086
-
Kreuzreaktivität
- Human, Ratte
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Leukemia inhibitory factor receptor protein (915-1086AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: WB:1:500-1:5000, IHC:1:500-1:1000, IF:1:200-1:500,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- LIFR (Leukemia Inhibitory Factor Receptor alpha (LIFR))
-
Andere Bezeichnung
- LIFR
-
Hintergrund
-
Background: Signal-transducing molecule. May have a common pathway with IL6ST. The soluble form inhibits the biological activity of LIF by blocking its binding to receptors on target cells.
Aliases: CD118 antibody, CD118 antigen antibody, FLJ98106 antibody, FLJ99923 antibody, Leukemia inhibitory factor receptor alpha antibody, Leukemia inhibitory factor receptor antibody, LIF R antibody, LIF receptor antibody, LIF-R antibody, Lifr antibody, LIFR_HUMAN antibody, SJS2 antibody, STWS antibody, SWS antibody
-
UniProt
- P42702
-
Pathways
- JAK-STAT Signalweg, Growth Factor Binding
Target
-